54
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Nomogram predicts survival benefit for non- metastatic esophageal cancer patients who underwent preoperative radiotherapy

, &
Pages 3657-3668 | Published online: 18 Sep 2018

References

  • DevesaSSBlotWJFraumeniJFJrChanging patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer199883204920539827707
  • SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin20166673026742998
  • RiceTWRuschVWApperson-HansenCWorldwide esophageal cancer collaborationDis Esophagus2009221819196264
  • AllumWHStenningSPBancewiczJLong-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancerJ Clin Oncol2009275062506719770374
  • GehJICrellinAMGlynne-JonesRPreoperative (neoadjuvant) chemoradiotherapy in oesophageal cancerBr J Surg20018833835611260097
  • EdgeSBBDComptonCCFritzAGGreeneFLTrottiAAJCC Cancer Staging Manual7th edSpringerNew York2010
  • RizkNPVenkatramanEBainsMSAmerican Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinomaJ Clin Oncol20072550751217290058
  • ChirieacLRSwisherSGAjaniJAPosttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationCancer20051031347135515719440
  • BergerACFarmaJScottWJComplete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survivalJ Clin Oncol2005234330433715781882
  • HirabayashiSKosugiSIsobeYDevelopment and external validation of a nomogram for overall survival after curative resection in serosa- negative, locally advanced gastric cancerAnn Oncol2014251179118424669009
  • LiuJGengQLiuZDevelopment and external validation of a prognostic nomogram for gastric cancer using the national cancer registryOncotarget20167358533586427016409
  • LiangWZhangLJiangGDevelopment and validation of a nomogram for predicting survival in patients with resected non-small- cell lung cancerJ Clin Oncol20153386186925624438
  • LiuJGengQChenSNomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomyOncotarget20167375563756527121054
  • HanDSSuhYSKongSHNomogram predicting long-term survival after d2 gastrectomy for gastric cancerJ Clin Oncol2012303834384023008291
  • EilRDiggsBSWangSJNomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysisCancer201412049249824194477
  • ShapiroJvan KlaverenDLagardeSMPrediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgeryBr J Surg20161031039104727115731
  • MarietteCPiessenGBriezNThe number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extentAnn Surg200824736537118216546
  • GreensteinAJLitleVRSwansonSJPrognostic significance of the number of lymph node metastases in esophageal cancerJ Am Coll Surg200820623924618222375
  • SeydelHGLeichmanLByhardtRPreoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG StudyInt J Radiat Oncol Biol Phys19881433353335460
  • KellerSMRyanLMCoiaLRHigh dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology GroupCancer199883190819169806648